Drug Profile
Exenatide/insulin lispro - Adocia
Alternative Names: BC Lis Exe; BioChaperone Lispro ExenatideLatest Information Update: 03 Oct 2023
Price :
$50
*
At a glance
- Originator Adocia
- Class
- Mechanism of Action Glucagon like peptide 1 receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 1 diabetes mellitus
Most Recent Events
- 03 Oct 2023 Discontinued - Preclinical for Type 1 diabetes mellitus in France (SC) (Adocia website, October 2023)
- 28 Feb 2021 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in France (SC, Injection)
- 05 Jan 2017 Preclinical trials in Type-1 diabetes mellitus in France (SC)